Humacyte, Inc.

HUMA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$18-$38$39-$21
Dep. & Amort.$2$2$2-$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$0$2$2
Change in WC-$4-$1-$10-$3
Other Non-Cash-$7$11-$62-$4
Operating Cash Flow-$24-$26-$29-$27
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$0-$0
Financing Activities
Debt Repay.-$1-$1-$1$2
Stock Issued$10$3$47$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$54-$0$0$48
Financing Cash Flow-$45$2$47$51
Forex Effect$0-$0$0$0
Net Chg. in Cash-$69-$25$18$24
Supplemental Information
Beg. Cash$88$63$95$71
End Cash$20$38$113$95
Free Cash Flow-$24-$27-$29-$27